American Society of Hematology, Blood Advances, 24(1), p. 2120-2123, 2017
DOI: 10.1182/bloodadvances.2017007013
Full text: Download
Key Points SEER data and a Bronx validation cohort demonstrate that Hispanics present with AML at younger age but have shorter survival than whites. Increased frequency of high-risk mutations in Hispanics provides a potential biologic explanation for poorer outcomes in Hispanics.